블로그
- 모더나 - 인티스메란 + 키트루다 병용 임상 3상, 평가지표 달성 [번역] https://news.modernatx.com/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-plus-keytruda-met-endpoints-of-rfs-and-dmfs-in-melanoma
- 하이앤드 오디오 시스템 Highend Audio Speaker Systems Vivid Audio Moya M1 Physically, that concept would evolve many times through the R&D phase but the vision remained unchanged : the non plus ultra of loudspeakers, able to handle anything with aplomb.
- 하이앤드 오디오 시스템 Highend Audio Speaker Systems Vivid Audio Moya M1 Physically, that concept would evolve many times through the R&D phase but the vision remained unchanged : the non plus ultra of loudspeakers, able to handle anything with aplomb.
- 모더나 - AACR 2026 암 학회 발표 주제 (4월 20일) First-Line mRNA-4359 plus pembrolizumab (pembro) in locally advanced or metastatic melanoma: Results from the phase 1/2 mRNA-4359-P101 study First-Line (1차 치료): 전에 이 병으로 항암치료를 받은 적이 없는 '신규 환자'를 뜻함 mRNA-
- 모더나 - AACR 2026 암 학회 발표 주제 (4월 20일) First-Line mRNA-4359 plus pembrolizumab (pembro) in locally advanced or metastatic melanoma: Results from the phase 1/2 mRNA-4359-P101 study First-Line (1차 치료): 전에 이 병으로 항암치료를 받은 적이 없는 '신규 환자'를 뜻함 mRNA-
- A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or ... A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial
- Phase III Trial Results Suggest a New Standard of Care in Metastatic HER2-Positive Breast Cancer Phase III Trial Results Suggest a New Standard of Care in Metastatic HER2-Positive Breast Cancer In the phase III DESTINY-Breast09 trial, first-line treatment with the antibody-drug conjugate fam-trastuzumab
동영상
-
SKIN
-
FLOAT
-
1004
-
Frankenstein
-
Gooey
-
PARASITE
-
Oil Surges Above $105, Arnott Warns of Bubble Risk
-
Sprunki Phase 3 Mod in Sprunki Plus [Roblox]
-
Sprunki Phase 1.5 Mod in Sprunki Plus [Roblox]
-
Patch Report #39.1 | Erangel: Subzero Begins, Gunplay Updates, and UGC Alpha Returns